Drug Shortage Report for BIO-IRBESARTAN

Last updated on 2019-08-21 History
Report ID 79107
Drug Identification Number 02446154
Brand name BIO-IRBESARTAN
Common or Proper name IRBESARTAN
Company Name BIOMED PHARMA
Market Status CANCELLED POST MARKET
Active Ingredient(s) IRBESARTAN
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-03-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-08-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-03-21 English Compare
v2 2019-03-21 French Compare
v3 2019-08-21 English Compare
v4 2019-08-21 French Compare

Showing 1 to 4 of 4